HeXun Biosciences Co Ltd(TW:6986)
NT$37.50+0.20 (+0.54%)
TW:6986
HeXun Biosciences Co Ltd financials statements
NT$37.50
At close:+0.20 (+0.54%)
HeXun Biosciences Co Ltd (6986) Financial Statements
HeXun Biosciences Co Ltd Financial Overview
HeXun Biosciences Co Ltd's market cap is currently NT$1.94B. The company's EPS TTM is NT$2.52; its P/E ratio is 14.13; and it has a dividend yield of 0.52%. HeXun Biosciences Co Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 25 | Dec 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 130.57M | NT$ 293.23M | NT$ 286.42M | NT$ 49.47M | NT$ 0.00 |
| Gross Profit | NT$ 113.73M | NT$ 245.15M | NT$ 260.67M | NT$ 44.61M | NT$ 0.00 |
| Operating Income | NT$ 27.37M | NT$ 118.00M | NT$ 155.73M | NT$ -3.55M | NT$ -50.66M |
| EBITDA | NT$ 55.64M | NT$ 146.95M | NT$ 187.36M | NT$ 11.17M | NT$ -29.51M |
| Net Income | NT$ 33.49M | NT$ 111.91M | NT$ 147.22M | NT$ -5.19M | NT$ -42.99M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 329.67M | NT$ 509.63M | NT$ 372.99M | NT$ 191.74M | NT$ 85.03M |
| Total Assets | NT$ 571.43M | NT$ 837.07M | NT$ 706.92M | NT$ 404.15M | NT$ 294.62M |
| Total Debt | NT$ 70.06M | NT$ 36.58M | NT$ 35.02M | NT$ 69.42M | NT$ 74.10M |
| Net Debt | NT$ -187.61M | NT$ -171.62M | NT$ -165.97M | NT$ -50.32M | NT$ -10.93M |
| Total Liabilities | NT$ 98.07M | NT$ 95.47M | NT$ 86.34M | NT$ 89.28M | NT$ 79.86M |
| Stockholders' Equity | NT$ 473.36M | NT$ 741.60M | NT$ 620.58M | NT$ 314.87M | NT$ 214.75M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 20.28M | NT$ 135.04M | NT$ 83.63M | NT$ 10.00M | NT$ -35.50M |
| Operating Cash Flow | NT$ 43.09M | NT$ 163.89M | NT$ 120.92M | NT$ 11.23M | NT$ -35.50M |
| Investing Cash Flow | NT$ -25.28M | NT$ -158.38M | NT$ -137.29M | NT$ -79.05M | NT$ -26.95M |
| Financing Cash Flow | NT$ 120.12M | NT$ 1.69M | NT$ -40.30M | NT$ 102.54M | NT$ 75.79M |
Currency in TWD
